A cannabinoid quinone inhibits angiogenesis by targeting vascular endothelial cells (full - 2006)http://molpharm.aspetjournals.org/content/70/1/51.long
A Cannabinoid Anticancer Quinone, HU-331, Is More Potent and Less Cardiotoxic Than Doxorubicin: A Comparative in Vivo Study (full - 2007)http://jpet.aspetjournals.org/content/322/2/646.full
HU-331, a novel cannabinoid-based anticancer topoisomerase II inhibitor (full – 2007) http://mct.aacrjournals.org/content/6/1/173.long
HU-331: a cannabinoid quinone, with uncommon cytotoxic properties and low toxicity (abst - 2007)http://www.ncbi.nlm.nih.gov/pubmed/17714026
Antitumorigenic Effects of Cannabinoids beyond Apoptosis (full – 2010) http://jpet.aspetjournals.org/conten...e-8f750e9c4a17
Characterization of HU-331 as a cannabinoid quinone inhibitor of topoisomerase II (abst – 2014)http://www.fasebj.org/content/28/1_S...6-4103f0c84daf
A Cannabinoid Anticancer Quinone, HU-331, Is More Potent and Less Cardiotoxic Than Doxorubicin: A Comparative in Vivo Study (full - 2007)http://jpet.aspetjournals.org/content/322/2/646.full
HU-331, a novel cannabinoid-based anticancer topoisomerase II inhibitor (full – 2007) http://mct.aacrjournals.org/content/6/1/173.long
HU-331: a cannabinoid quinone, with uncommon cytotoxic properties and low toxicity (abst - 2007)http://www.ncbi.nlm.nih.gov/pubmed/17714026
Antitumorigenic Effects of Cannabinoids beyond Apoptosis (full – 2010) http://jpet.aspetjournals.org/conten...e-8f750e9c4a17
Characterization of HU-331 as a cannabinoid quinone inhibitor of topoisomerase II (abst – 2014)http://www.fasebj.org/content/28/1_S...6-4103f0c84daf